Zdrowie i gospodarka · 08/06/2023
FDA Clears Path for Generic Buspirone Hydrochloride Capsules
The FDA has determined that BUSPAR capsules in various strengths were not withdrawn due to safety or effectiveness concerns, paving the way for potential approval of generic versions of the medication.